Elías D. Á.
- Country
- Spain
- Department
- Endocrinology & Nutrition
Research Overview
- Phase 3 Randomized Double-Blind Placebo-Controlled Study of KAI-9531 in Adults With Obesity or Overweight and Diabetes
- Phase 3 Study of KAI-9531 in Adults With Obesity or Overweight With Weight-Related Comorbidities Without Diabetes
- Pan-European proof-of-concept study comparing Decentralised Clinical Trial (DCT) and hybrid approaches to conventional clinical trial approaches in patients with Type 2 diabetes mellitus treated with Toujeo®
Data & Insights
Has run more than one trial at 236 of 680 partner sites.
Specializations
Endocrinology and Metabolic Disease
The investigator is involved in clinical research on type 2 diabetes mellitus, obesity, overweight, and familial hypercholesterolemia, with interest in cardiometabolic risk reduction and long-term disease control.
- Type 2 diabetes mellitus
- Obesity and overweight
- Familial hypercholesterolemia
- Resistant hypertension
His therapeutic focus also includes prevention of cardiovascular disease in patients with metabolic disorders and treatment-resistant blood pressure control.
Haematology and Blood Disorders
His research landscape includes multiple studies in myelodysplastic syndromes, acute myeloid leukemia, multiple myeloma, and lymphoid malignancies, with attention to transfusion-dependent anaemia and relapsed or refractory disease.
- Myelodysplastic syndromes
- Acute myeloid leukemia
- Multiple myeloma
- Chronic lymphocytic leukemia
He is also engaged in research on haemophilia A, haemophilia B, and congenital antithrombin deficiency.
Oncology
His trial activity spans a broad oncology portfolio, especially breast cancer, non-small cell lung cancer, hepatocellular carcinoma, colorectal cancer, and urothelial carcinoma, reflecting interest in both solid tumours and advanced metastatic disease.
- Breast cancer
- Non-small cell lung cancer
- Hepatocellular carcinoma
- Colorectal cancer
He is also involved in research on melanoma, gastric and gastroesophageal junction cancer, prostate cancer, and neuroendocrine tumours.
Respiratory and Pulmonary Fibrosis
The investigator participates in studies focused on idiopathic pulmonary fibrosis, progressive pulmonary fibrosis, systemic sclerosis-associated interstitial lung disease, and chronic obstructive pulmonary disease, alongside broader respiratory tract disease research.
- Idiopathic pulmonary fibrosis
- Progressive pulmonary fibrosis
- Systemic sclerosis-associated interstitial lung disease
- Chronic obstructive pulmonary disease
His therapeutic interests extend to pulmonary arterial hypertension and other chronic interstitial lung conditions.
Cardiovascular and Neurologic Disorders
His clinical research includes atrial fibrillation, heart failure, stroke, and inherited or acquired vascular risk states, together with selected studies in neurological and psychiatric disease.
- Atrial fibrillation
- Heart failure
- Acute ischemic stroke
- Major depressive disorder
He is also involved in research on Parkinson's disease, Tourette’s disorder, and schizophrenia.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.